POGO

  • Staff List
  • Contact Us

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Virtual Education
    • Indigenous Resource Guide
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Monthly Donations
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

Blog

POGO > Blog > risk stratification
[sharethis]

Tag: risk stratification


Risk Stratification in Neuroblastoma

Posted on March 3, 2014 by admin


Presentation Description:
Neuroblastoma is the most common extra-cranial solid tumor in children. It is a heterogeneous malignancy with widely variable behaviour, from spontaneous regression to an extremely aggressive form of metastatic disease. Prognosis ranges from low to intermediate patients having near overall survival to high risk patients with a less than 40% survival. Neuroblastoma proves to be a paradigm for the use of biologic prognostic factors to tailor therapy to low, intermediate and high risk neuroblastoma.

The development of the International Neuroblastoma Risk Group Task Force (INRG) has lead the way in identifying and confirming biological and genetic markers to help understand the molecular pathogenesis of neuroblastoma. These markers have led to the development of protocols that look at minimizing therapy for low to intermediate risk patients and in contrast intensifying therapy to high risk patients.

This presentation provided the audience with an overview of neuroblastoma with a focus on understanding neuroblastoma biology and prognostic features and how this impacts risk stratification and current therapy.

Speaker:
Denise Mills, RN(EC), MN, NP
Nurse Practitioner, Division of Haematology/Oncology
The Hospital for Sick Children, Toronto
Lawrence S. Bloomberg Cross Appointment at Faculty of Nursing
University of Toronto, Toronto

Posted in 2013 Pre-Symposium Nursing Seminar - Innovation in Pediatric Oncology Nursing, Education for Health Professionals | Tagged 2013 Pre-Symposium Nursing Seminar, genetic markers, neuroblastoma, risk stratification, solid tumours

Donate

Blog

Education Portal
Survivor Conference
All Categories

Categories

Newsletter Sign-Up

Please leave this field empty

@POGO4Kids

March 17, 2023

OPACC is proud to present our next free virtual presentation: "An Introduction to the POGO School and Work Transitions Program" ft. guest speaker Helen from @POGO4kids! See poster for details & register at: http://tinyurl.com/opacczoom
#childhoodcancersurvivors

Reply on Twitter 1636831327281356800 Retweet on Twitter 1636831327281356800 2 Like on Twitter 1636831327281356800 3 Twitter 1636831327281356800

Follow @POGO4Kids

Quick Links

  • For Professionals
    • Read Cancer Care Plan
    • Review our Guidelines
    • Request Research Data
  • Families & Kids
    • Get POGO AfterCare
    • Meet with a POGO Nurse
    • Get Care Closer to Home
  • For Survivors
    • Find Local Resources
    • Set Goals for your Future
    • Educate Yourself
  • Get Involved
    • Host an Event for POGO
    • Volunteer with POGO
    • Partner with POGO
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Virtual Education
    • Indigenous Resource Guide
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Monthly Donations
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2022 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 |
1-855-FOR POGO (367-7646) | Contact Us | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |